Gilead Sciences, Inc. recalls Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Fos
Recalled January 5, 2022 · FDA recall D-0299-2022 · Gilead Sciences
Hazard
Presence of Particulate Matter: investigation into a customer complaint confirmed the presence of glass particulates. · FDA Class I
Units
53,473 vials
Sold at
Nationwide in the USA
Description
Presence of Particulate Matter: investigation into a customer complaint confirmed the presence of glass particulates.
Product
Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2
Manufacturer(s)
Gilead Sciences, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →